News | January 13, 2025
Apotex acquires US rights to PROVIGIL and NUVIGIL
PROVIGIL and NUVIGIL are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy
PROVIGIL and NUVIGIL are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy
According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
Aims to become India’s leading cancer testing company
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
